Literature DB >> 21063900

Modulation of lupus phenotype by adiponectin deficiency in autoimmune mouse models.

Jennifer Parker1, Hanni Menn-Josephy, Bari Laskow, Yukihiro Takemura, Tamar Aprahamian.   

Abstract

Adiponectin is an adipocyte-derived cytokine with anti-inflammatory properties. Paradoxically, circulating adiponectin levels are increased in a number of inflammatory diseases. Thus, we sought to define the role of adiponectin deficiency in mouse models of autoimmunity. Adiponectin-deficient mice on a C57BL/6 background do not develop an autoimmune phenotype. Autoimmunity was also not observed in adiponectin-deficient mice generated on the permissive MRL background. However, adiponectin deficiency exacerbated the autoimmune phenotype of MRL-lpr mice. Compared with MRL-lpr mice, MRL-lpr.apn(-/-) mice displayed greater lymphadenopathy and splenomegaly, as well as increased anti-nuclear antibody and anti-dsDNA production. In addition, evaluation of the kidney revealed larger glomerular tuft size, crescent formation, increased IgG and C3 deposits, and mesangial expansion in the MRL-lpr.apn(-/-) mice. The effects of adiponectin deficiency on the autoimmune phenotypes were more pronounced in female versus male mice. These data show that, while adiponectin deficiency is not sufficient to confer autoimmunity, adiponectin acts as a negative modulator of the autoimmune phenotype in a murine model of lupus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21063900      PMCID: PMC3505060          DOI: 10.1007/s10875-010-9486-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  45 in total

1.  Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms.

Authors:  Rei Shibata; Kaori Sato; David R Pimentel; Yukihiro Takemura; Shinji Kihara; Koji Ohashi; Tohru Funahashi; Noriyuki Ouchi; Kenneth Walsh
Journal:  Nat Med       Date:  2005-09-11       Impact factor: 53.440

2.  A novel serum protein similar to C1q, produced exclusively in adipocytes.

Authors:  P E Scherer; S Williams; M Fogliano; G Baldini; H F Lodish
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

3.  Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study.

Authors:  Takeshi Isobe; Shigeyuki Saitoh; Satoru Takagi; Hiroshi Takeuchi; Yu Chiba; Nobuo Katoh; Kazuaki Shimamoto
Journal:  Eur J Endocrinol       Date:  2005-07       Impact factor: 6.664

4.  The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects.

Authors:  Clinton R Bruce; Valerie A Mertz; George J F Heigenhauser; David J Dyck
Journal:  Diabetes       Date:  2005-11       Impact factor: 9.461

5.  Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus.

Authors:  Brad H Rovin; Huijuan Song; Lee A Hebert; Tibor Nadasdy; Gyongyi Nadasdy; Daniel J Birmingham; Chack Yung Yu; Haikady N Nagaraja
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

6.  Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity.

Authors:  M C Bickerstaff; M Botto; W L Hutchinson; J Herbert; G A Tennent; A Bybee; D A Mitchell; H T Cook; P J Butler; M J Walport; M B Pepys
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

Review 7.  Adipose tissue, inflammation, and cardiovascular disease.

Authors:  Anders H Berg; Philipp E Scherer
Journal:  Circ Res       Date:  2005-05-13       Impact factor: 17.367

8.  Adiponectin-mediated modulation of hypertrophic signals in the heart.

Authors:  Rei Shibata; Noriyuki Ouchi; Masahiro Ito; Shinji Kihara; Ichiro Shiojima; David R Pimentel; Masahiro Kumada; Kaori Sato; Stephan Schiekofer; Koji Ohashi; Tohru Funahashi; Wilson S Colucci; Kenneth Walsh
Journal:  Nat Med       Date:  2004-11-21       Impact factor: 53.440

9.  Adiponectin replenishment ameliorates obesity-related hypertension.

Authors:  Koji Ohashi; Shinji Kihara; Noriyuki Ouchi; Masahiro Kumada; Koichi Fujita; Aki Hiuge; Toshiyuki Hibuse; Miwa Ryo; Hitoshi Nishizawa; Norikazu Maeda; Kazuhisa Maeda; Rei Shibata; Kenneth Walsh; Tohru Funahashi; Iichiro Shimomura
Journal:  Hypertension       Date:  2006-05-01       Impact factor: 10.190

10.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

Authors:  R Watanabe-Fukunaga; C I Brannan; N G Copeland; N A Jenkins; S Nagata
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

View more
  10 in total

Review 1.  Adipokines: a link between obesity and cardiovascular disease.

Authors:  Kazuto Nakamura; José J Fuster; Kenneth Walsh
Journal:  J Cardiol       Date:  2013-12-16       Impact factor: 3.159

Review 2.  Metabolic determinants of lupus pathogenesis.

Authors:  Xiangyu Teng; Josephine Brown; Seung-Chul Choi; Wei Li; Laurence Morel
Journal:  Immunol Rev       Date:  2020-03-12       Impact factor: 12.988

Review 3.  Adiponectin in inflammatory and immune-mediated diseases.

Authors:  Giamila Fantuzzi
Journal:  Cytokine       Date:  2013-07-11       Impact factor: 3.861

Review 4.  Adiponectin: a therapeutic target in the antiphospholipid syndrome?

Authors:  Mirjana B Bećarević; Božana S Nikolić; Svetlana D Ignjatović
Journal:  Rheumatol Int       Date:  2019-06-18       Impact factor: 2.631

5.  Complement protein C1q and adiponectin stimulate Mer tyrosine kinase-dependent engulfment of apoptotic cells through a shared pathway.

Authors:  Manuel D Galvan; Holly Hulsebus; Thomas Heitker; Erliang Zeng; Suzanne S Bohlson
Journal:  J Innate Immun       Date:  2014-06-17       Impact factor: 7.349

6.  Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARγ/RORγt Pathway.

Authors:  Kai Zhang; Yawei Guo; Zhenzhen Ge; Zhihui Zhang; Yurong Da; Wen Li; Zimu Zhang; Zhenyi Xue; Yan Li; Yinghui Ren; Long Jia; Koon-Ho Chan; Fengrui Yang; Jun Yan; Zhi Yao; Aimin Xu; Rongxin Zhang
Journal:  Mol Neurobiol       Date:  2016-08-11       Impact factor: 5.590

Review 7.  Emerging role of adipokines in systemic lupus erythematosus.

Authors:  Hong-Miao Li; Tian-Ping Zhang; Rui-Xue Leng; Xiang-Pei Li; Xiao-Mei Li; Hai-Rong Liu; Dong-Qing Ye; Hai-Feng Pan
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

8.  Adiponectin in cardiovascular inflammation and obesity.

Authors:  Tamar R Aprahamian; Flora Sam
Journal:  Int J Inflam       Date:  2011-09-15

9.  Fish oil N-3 fatty acids increase adiponectin and decrease leptin levels in patients with systemic lupus erythematosus.

Authors:  Marcell Alysson Batisti Lozovoy; Andréa Name Colado Simão; Helena Kaminami Morimoto; Bruna Miglioranza Scavuzzi; Tathiana Veiga Mayumi Iriyoda; Edna Maria Vissoci Reiche; Rubens Cecchini; Isaias Dichi
Journal:  Mar Drugs       Date:  2015-02-16       Impact factor: 5.118

10.  KS23, a novel peptide derived from adiponectin, inhibits retinal inflammation and downregulates the proportions of Th1 and Th17 cells during experimental autoimmune uveitis.

Authors:  Tian Niu; Lu Cheng; Hanying Wang; Shaopin Zhu; Xiaolu Yang; Kun Liu; Huiyi Jin; Xun Xu
Journal:  J Neuroinflammation       Date:  2019-12-28       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.